• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[儿童和青少年耐多药结核病]

[Drug resistant tuberculosis in children and adolescents].

作者信息

Aksenova V A, Luginova E F

出版信息

Probl Tuberk. 2003(1):25-8.

PMID:12652979
Abstract

The paper presents the results of a follow-up of children and adolescents who isolate drug-resistant Mycobacterium tuberculosis (MBT) strains of those with manifestations of tuberculosis and preserved sensitivity to antibacterial agents. Bacterial isolation in children and adolescents is scanty and multiple. There is a high rate of resistance to isoniazid, streptomycin, and rifampicin. The vast majority of children and adolescents who isolate drug-resistant MBT strains have been found to contact a patient who also isolate drug-resistant MBT. The drug sensitivity of MBT in patients is identical to that of sources of their contamination. Most patients with drug-resistant tuberculosis have been ascertained as having been registered in dispensaries and treated with drugs, which suggests that the use of chemotherapy in prophylactic doses, particularly in patients contacting a bacterial isolator, does not prevent local tuberculosis.

摘要

本文介绍了对儿童和青少年进行随访的结果,这些儿童和青少年分离出对结核病有临床表现且对抗菌药物仍敏感的耐多药结核分枝杆菌(MBT)菌株。儿童和青少年中的细菌分离数量少且多样。对异烟肼、链霉素和利福平的耐药率很高。已发现绝大多数分离出耐多药MBT菌株的儿童和青少年与同样分离出耐多药MBT的患者有接触。患者中MBT的药敏性与其污染源的药敏性相同。大多数耐多药结核病患者已被确定在药房登记并接受过药物治疗,这表明使用预防剂量的化疗,特别是在接触细菌隔离者的患者中,不能预防局部结核病。

相似文献

1
[Drug resistant tuberculosis in children and adolescents].[儿童和青少年耐多药结核病]
Probl Tuberk. 2003(1):25-8.
2
[Treatment and outcomes of tuberculosis with multidrug resistance of MBT in children and adolescents].
Probl Tuberk Bolezn Legk. 2007(5):20-2.
3
[Efficiency of preventive chemotherapy in children and adolescents from the bacterial isolation foci of tuberculous infection].[结核感染细菌隔离点儿童和青少年预防性化疗的效果]
Probl Tuberk Bolezn Legk. 2006(1):3-6.
4
[Efficacy of chemotherapy for tuberculosis in patients who isolate drug-resistant strains of M. tuberculosis with different genotypes].[不同基因型结核分枝杆菌耐药菌株分离患者的结核病化疗疗效]
Probl Tuberk Bolezn Legk. 2004(8):25-8.
5
[Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].[化疗与静脉输注溶解臭氧同时使用时分枝杆菌耐药性的变化]
Probl Tuberk Bolezn Legk. 2004(7):32-5.
6
[Efficacy of treatment for pulmonary tuberculosis with multidrug mycobacterial resistance].[多药耐药性肺结核的治疗效果]
Probl Tuberk. 2002(12):18-23.
7
[Estimation of the possibilities of using unified chemotherapy regimens in new cases of pulmonary tuberculosis in old-age children and adolescents].[老年儿童和青少年新发肺结核病例中使用统一化疗方案的可能性评估]
Probl Tuberk Bolezn Legk. 2009(1):33-6.
8
[Primary drug resistance of Mycobacterium tuberculosis in patients with new-onset destructive pulmonary tuberculosis].新发破坏性肺结核患者中结核分枝杆菌的原发性耐药性
Probl Tuberk Bolezn Legk. 2009(4):37-9.
9
[A role of the biological chip test in the determination of rifampicin resistance in Mycobacteria in adolescents with active pulmonary tuberculosis].[生物芯片检测在青少年活动性肺结核分枝杆菌利福平耐药性测定中的作用]
Probl Tuberk Bolezn Legk. 2004(8):28-30.
10
[Ways of overcoming drug resistance in patients with pulmonary tuberculosis].[肺结核患者克服耐药性的方法]
Probl Tuberk. 2002(3):16-8.